Creating a new tool to measure opioid withdrawal symptoms
Developing an FDA-Qualified Clinical Outcomes Assessment for Opioid Withdrawal
This study is working to create a new tool to better understand and measure the symptoms of opioid withdrawal, using input from people who have experienced it, so that doctors can more effectively help those going through this tough time.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | City College of New York NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11134972 on NIH RePORTER |
What this research studies
This research aims to develop and validate a Clinical Outcome Assessment (COA) specifically for opioid withdrawal, following FDA guidelines. It addresses the inconsistencies in current assessment methods by incorporating feedback from individuals with lived experiences of opioid use disorder (OUD). The project will involve focus groups and cognitive interviews to gather diverse perspectives, ensuring the new assessment tool accurately reflects the symptoms and challenges faced by patients. The goal is to create a reliable measure that can be used to evaluate the effectiveness of medications and interventions for managing opioid withdrawal.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced opioid withdrawal or have a diagnosis of opioid use disorder.
Not a fit: Patients who have not experienced opioid withdrawal or do not have a history of opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for opioid withdrawal, improving patient outcomes and experiences during recovery.
How similar studies have performed: Previous research has shown success in developing clinical outcome assessments for other conditions, indicating potential for this approach to be effective in opioid withdrawal as well.
Where this research is happening
New York, United States
- City College of New York — New York, United States (Active)
Researchers
- Principal investigator: Brandt, Laura — City College of New York
- Study coordinator: Brandt, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.